SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-207226
Filing Date
2019-07-30
Accepted
2019-07-30 17:29:39
Documents
13
Period of Report
2019-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d783078d8k.htm   iXBRL 8-K 28247
2 EX-99.1 d783078dex991.htm EX-99.1 163634
  Complete submission text file 0001193125-19-207226.txt   340936

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA myl-20190729.xsd EX-101.SCH 3032
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE myl-20190729_lab.xml EX-101.LAB 19541
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myl-20190729_pre.xml EX-101.PRE 12243
6 EXTRACTED XBRL INSTANCE DOCUMENT d783078d8k_htm.xml XML 3509
Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Filer) CIK: 0001623613 (see all company filings)

IRS No.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-199861 | Film No.: 19986547
SIC: 2834 Pharmaceutical Preparations